Article
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer.
International journal of antimicrobial agents - 1 Nov 2013
Ha Young Eun, Kang Cheol-In, Cha Min Kyeong, Park So Yeon, Wi Yu Mi, Chung Doo Ryeon, Peck Kyong Ran, Lee Nam Yong, Song Jae-Hoon
Abstract excerpt
Patients with cancer can be vulnerable to infection with antimicrobial-resistant pathogens such as extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. A cohort study was performed to evaluate the epidemiology and impact of ESBL-producing Escherichia coli (ESBL-EC) bacteraemia on the outcomes of adult patients with cancer. During the 2.5-year study period, a total of 350 cases of E. coli bacteraemia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
